Barry Bloom | Academic Influence

Barry Bloom's AcademicInfluence.com Rankings

Barry Bloom

Biology

#1610

World Rank

#2650

Historical Rank

#783

USA Rank

Immunology

#72

World Rank

#78

Historical Rank

#25

USA Rank

biology Degrees

Download Badge

Biology

Barry Bloom's Degrees

Bachelors Biology Amherst College
Masters Medicine Tufts University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Barry Bloom Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.

(See a Problem?)

Barry Bloom's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response (2006) (3624)
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection (1993) (2541)
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. (1999) (1821)
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. (1995) (1779)
Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity (1966) (1554)
New use of BCG for recombinant vaccines (1991) (1468)
Tuberculosis: Commentary on a Reemergent Killer (1992) (1387)
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. (1991) (1114)
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages (1992) (1092)
An antimicrobial activity of cytolytic T cells mediated by granulysin. (1998) (1083)
Natural and synthetic non-peptide antigens recognized by human γδ T cells (1995) (952)
Tuberculosis Pathogenesis, Protection, and Control (1994) (926)
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. (1992) (848)
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. (1994) (845)
CD1-restricted T cell recognition of microbial lipoglycan antigens. (1995) (795)
Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. (2005) (667)
Burden of disease--implications for future research. (2001) (610)
Differential effects of cytolytic T cell subsets on intracellular infection. (1997) (591)
Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions (1989) (582)
Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. (1999) (552)
Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells (1995) (497)
Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages (2011) (472)
Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. (1993) (443)
Ipr1 gene mediates innate immunity to tuberculosis (2005) (443)
Genetic systems for mycobacteria. (1991) (440)
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells (2005) (433)
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis (1995) (423)
Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages (1991) (417)
Mutually dependent secretion of proteins required for mycobacterial virulence. (2005) (387)
Nonpeptide ligands for human gamma delta T cells. (1994) (374)
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. (1995) (369)
In vitro methods in cell mediated and tumor immunity (1976) (356)
Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses (2013) (344)
Lysogeny and transformation in mycobacteria: stable expression of foreign genes. (1988) (321)
Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. (1985) (320)
Introduction of foreign DNA into mycobacteria using a shuttle phasmid (1987) (312)
An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. (1997) (307)
Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. (2000) (307)
Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. (1995) (305)
Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae (1985) (300)
Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. (2000) (292)
Cytokine patterns of immunologically mediated tissue damage. (1992) (290)
V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. (1995) (290)
Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. (1997) (289)
Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. (1978) (277)
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. (1998) (272)
Attenuation of and Protection Induced by a Leucine Auxotroph of Mycobacterium tuberculosis (2000) (268)
An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. (1996) (257)
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. (1989) (257)
Revisiting and revising suppressor T cells. (1992) (255)
The BCG Experience: Implications for Future Vaccines against Tuberculosis (1994) (253)
Pathogenesis of Tuberculosis: Interaction of Mycobacterium tuberculosis with Macrophages (1993) (251)
In vitro approaches to the mechanism of cell-mediated immune reactions. (1971) (251)
Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth (2002) (250)
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. (1993) (239)
Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. (1993) (227)
Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction (1975) (222)
Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 (2004) (220)
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. (1991) (217)
Granulysin, a T Cell Product, Kills Bacteria by Altering Membrane Permeability1 (2000) (217)
The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. (1981) (216)
Building a tuberculosis-free world: The Lancet Commission on tuberculosis (2019) (214)
In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis (1995) (213)
In vitro methods in cell-mediated immunity (1971) (209)
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. (2000) (207)
Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. (1968) (206)
Games parasites play: how parasites evade immune surveillance (1979) (206)
Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid (1984) (203)
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction (1993) (200)
Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. (1996) (193)
Learning from lesions: patterns of tissue inflammation in leprosy. (1988) (192)
Contribution of Receptor Editing to the Antibody Repertoire (2007) (191)
Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease (2003) (183)
Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. (1995) (183)
Interferons and the immune system (1980) (183)
Stigma variations: observations on suppressor T cells and leprosy. (1992) (180)
Auxotrophic vaccines for tuberculosis (1996) (178)
On the heterogeneity of murine natural killer cells (1981) (175)
Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. (1996) (173)
IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASIS (1987) (170)
Mycobacterial infection of macrophages results in membrane-permeable phagosomes. (1999) (166)
Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages (1993) (166)
The folate pathway is a target for resistance to the drug para‐aminosalicylic acid (PAS) in mycobacteria (2004) (160)
Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates (1996) (159)
Effects of protein calorie malnutrition on tuberculosis in mice. (1996) (157)
Insertional mutagenesis and illegitimate recombination in mycobacteria. (1991) (155)
A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. (1998) (154)
Macrophages Acquire Neutrophil Granules for Antimicrobial Activity against Intracellular Pathogens1 (2006) (153)
Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. (1997) (153)
Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice (1979) (152)
Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice. (1978) (151)
Immunization by a bacterial aerosol (2008) (150)
Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi (2003) (148)
The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. (1999) (148)
A T Helper Cell 2 (Th2) Immune Response against Non-self Antigens Modifies the Cytokine Profile of Autoimmune T Cells and Protects against Experimental Allergic Encephalomyelitis (1997) (147)
Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization (1994) (146)
A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein (1992) (146)
An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. (1997) (142)
Meeting Cholera's Challenge to Haiti and the World: A Joint Statement on Cholera Prevention and Care (2011) (142)
Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli (1986) (140)
Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. (1975) (138)
Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions (1986) (136)
Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. (1995) (135)
Studies on the mechanism of NK cell lysis. (1982) (134)
Vaccines for the Third World (1989) (133)
Protection Elicited by a Double Leucine and Pantothenate Auxotroph of Mycobacterium tuberculosis in Guinea Pigs (2004) (130)
Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. (1999) (128)
Role of Macrophage Oxidative Burst in the Action of Anthrax Lethal Toxin (1994) (128)
Lepromin-induced suppressor cells in patients with leprosy. (1979) (127)
Human Double-Negative T Cells in Systemic Lupus Erythematosus Provide Help for IgG and Are Restricted by CD1c1 (2000) (125)
Immunological Unresponsiveness in Leprosy (1984) (124)
Structure of the Heat Shock Protein Chaperonin-10 of Mycobacterium leprae (1996) (124)
Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. (1999) (122)
Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. (1999) (120)
Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. (1981) (117)
A novel transposon trap for mycobacteria: isolation and characterization of IS1096 (1991) (114)
The evolving relation between humans and Mycobacterium tuberculosis. (1998) (114)
Dual Immunological Unresponsiveness Induced by Cell Membrane Coupled Hapten or Antigen* (1966) (113)
Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis (1980) (110)
Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. (1998) (110)
Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence (1994) (109)
Immunoprophylactic trial with combined Mycobacterium Leprae/BCG vaccine against leprosy: preliminary results (1992) (109)
Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. (2008) (107)
Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. (1991) (107)
IL-32 is a molecular marker of a host defense network in human tuberculosis (2014) (107)
Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. (1979) (106)
Granulysin: a lethal weapon of cytolytic T cells. (1999) (105)
Interferon as a mediator of human lymphocyte suppression (1980) (104)
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization (1989) (103)
The Global Health System: Actors, Norms, and Expectations in Transition (2010) (102)
The major native proteins of the leprosy bacillus. (1990) (102)
The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. (1978) (102)
Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. (1989) (101)
Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. (1980) (101)
Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination. (1977) (100)
Suppressor T lymphocytes from lepromatous leprosy skin lesions. (1986) (100)
Interaction of the sensor module of Mycobacterium tuberculosis H37Rv KdpD with members of the Lpr family (2003) (99)
Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. (2012) (97)
Immunological destruction of herpes simplex virus I infected cells (1974) (96)
Back to a frightening future (1992) (95)
Drying a tuberculosis vaccine without freezing (2007) (94)
Role of NK cells in protection of mice against herpes simplex virus-1 infection. (1987) (93)
Interferon-gamma-induced transcriptional activation is mediated by protein kinase C. (1988) (93)
Interferon responses of leukocytes in multiple sclerosis (1981) (92)
Dissociation of MIF production and cell proliferation. (1972) (90)
A PLAQUE ASSAY FOR ENUMERATING ANTIGEN-SENSITIVE CELLS IN DELAYED-TYPE HYPERSENSITIVITY (1970) (87)
STUDIES ON THE MIGRATION INHIBITORY FACTOR ASSOCIATED WITH DELAYED‐TYPE HYPERSENSIVITY: CYTODYNAMICS AND SPECIFICITY (1967) (85)
Genetics of murine resistance to Trypanosoma cruzi (1982) (84)
A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy (2017) (83)
In situ characterization of the cellular immune response in American cutaneous leishmaniasis. (1985) (83)
Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. (1992) (83)
Activated suppressor T cells in leprosy. (1982) (83)
Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. (1985) (81)
Studies of in vitro infection by Trypanosoma cruzi. I. Ultrastructural studies on the invasion of macrophages and L-cells. (1975) (80)
Resistance of Trypanosoma cruzi to killing by macrophages (1975) (76)
Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. (1989) (76)
Mycobacterium tuberculosis Rv2224c modulates innate immune responses (2008) (76)
Evidence for a superantigen in human tuberculosis. (1994) (75)
Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria (1996) (73)
ON THE RELATION OF PRODUCTS OF ACTIVATED LYMPHOCYTES TO CELL-MEDIATED CYTOLYSIS (1974) (72)
Macrophage variants in oxygen metabolism (1980) (70)
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae (1987) (68)
Major Infectious Diseases: Key Messages from Disease Control Priorities, Third Edition (2017) (67)
Mechanisms of Pathogenesis in Tuberculosis (1994) (67)
The pursuit of global health: the relevance of engagement for developed countries (1998) (67)
The Highest Attainable Standard: Ethical Issues in AIDS Vaccines (1998) (66)
The Global Health System: Lessons for a Stronger Institutional Framework (2010) (66)
A Study of the Importance of Education and Cost Incentives on Individual Food Choices at the Harvard School of Public Health Cafeteria (2008) (66)
Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone (1997) (65)
Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene. (1990) (64)
Identification of a Mycobacterium bovisBCG Auxotrophic Mutant That Protects Guinea Pigs against M. bovis and Hematogenous Spread of Mycobacterium tuberculosis without Sensitization to Tuberculin (2000) (62)
CELL-MEDIATED IMMUNITY IN VIRAL INFECTIONS (1975) (62)
Modulation of Fc-mediated phagocytosis by cyclic AMP and insulin in a macrophage-like cell line. (1977) (62)
Recombinant bacille Calmette-Guérin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia. (1997) (61)
Effects of Mitomycin C on the Cellular Transfer of Delayed-Type Hypersensitivity in the Guinea Pig (1964) (61)
Functional γδ T-lymphocyte Defect Associated with Human Immunodeficiency Virus Infections (1997) (61)
Learning from leprosy: a perspective on immunology and the Third World. (1986) (61)
Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription (1990) (60)
Persisting problems in tuberculosis (1998) (60)
Immunological significance of Mycobacterium leprae cell walls. (1988) (60)
Antigenic variants of measles virus (1981) (59)
High‐Dose Vitamin D3 during Tuberculosis Treatment in Mongolia. A Randomized Controlled Trial (2017) (58)
Isolation and characterization of the aspartokinase and aspartate semialdehyde dehydrogenase operon from mycobacteria (1994) (58)
Recombinant bacille Calmette-Guérin priming against measles. (1995) (58)
Migration inhibitory factor associated with delayed-type hypersensitivity. (1968) (57)
3 Persisting problems in tuberculosis (1998) (57)
IMMUNOLOGICAL ADJUVANTS AND THE MECHANISM OF CELL COOPERATION (1972) (56)
Does transfer factor act specifically or as an immunologic adjuvant? (1973) (56)
Identification of expression signals of the mycobacteriophages Bxb1, L1 and TM4 using the Escherichia-Mycobacterium shuttle plasmids pYUB75 and pYUB76 designed to create translational fusions to the lacZ gene. (1992) (56)
The generation of human monocyte/macrophage cell lines (1983) (56)
Expression of adhesion molecules in leprosy lesions (1991) (55)
TB or Not TB: That Is No Longer the Question (2013) (55)
Restricted Replication of Vesicular Stomatitis Virus in Human Lymphoblastoid Cells (1973) (54)
Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies. (2009) (54)
Characterization of measles polypeptides by monoclonal antibodies. (1981) (54)
The vaccine book. (2003) (53)
Production of migration inhibition factor (MIF) and an inducer of plasminogen activator (IPA) by subsets of T cells in MLC. (1978) (53)
Bacterial vaccine vectors and bacillus Calmette-Guérin. (1995) (53)
Prospects for vaccines to protect against AIDS, tuberculosis, and malaria. (2001) (52)
"When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination. (2020) (52)
ON THE NUMBER AND NATURE OF ANTIGEN-SENSITIVE LYMPHOCYTES IN THE BLOOD OF DELAYED-HYPERSENSITIVE HUMAN DONORS (1971) (51)
Genetic analysis of the role of cAMP in mediating effects of interferon. (1982) (51)
Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. (1997) (51)
Isolation of variants in phagocytosis of a macrophage-like continuous cell line (1977) (50)
In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum. (1986) (49)
Evidence for functional subsets of CD4+ and CD8+ T cells in human disease: lymphokine patterns in leprosy. (1992) (49)
Genetic transformation of BCG. (1989) (49)
T-cell receptors of human suppressor cells (1987) (49)
Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. (1996) (48)
Immunity to infection. (1998) (48)
Complement potentiates the degradation of myelin proteins by plasmin: Implications for a mechanism of inflammatory demyelination (1986) (48)
Oxygen metabolism in cloned macrophage cell lines: glucose dependence of superoxide production, metabolic and spectral analysis. (1984) (48)
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria (2018) (47)
Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells (1984) (47)
Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection. (1994) (47)
Lipoarabinomannan-Responsive Polycytotoxic T Cells Are Associated with Protection in Human Tuberculosis. (2016) (47)
Development of BCG as a recombinant vaccine vehicle. (1990) (47)
Studies on the interactions between viruses and lymphocytes. (1977) (46)
The death and resurrection of tuberculosis (1999) (46)
Isolation and characterization of the highly immunogenic cell wall-associated protein of Mycobacterium leprae. (1989) (44)
Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones. (1989) (44)
Tuberculosis--the global view. (2002) (43)
Recombinant BCG as a candidate oral vaccine vector. (1990) (43)
Cytotoxic T lymphocytes in resistance to tuberculosis. (1998) (43)
Degradation of the P0, P1, and Pr, Proteins in Peripheral Nervous System Myelin by Plasmin: Implications Regarding the Role of Macrophages in Demyelinating Diseases (1981) (42)
Reconstitution of a variant macrophage cell line defective in oxygen metabolism with a H2O2-generating system. (1982) (42)
Use of recombinant BCG as a vaccine delivery vehicle. (1992) (42)
Genetic relationships among Mycobacterium leprae, Mycobacterium tuberculosis, and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence (1989) (41)
Sodium channel mutation leading to saxitoxin resistance in clams increases risk of PSP (2010) (41)
The public health crisis of underimmunisation: a global plan of action. (2019) (41)
Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate. (2011) (41)
Direct presentation of non-peptide prenyl pyrophosphate antigens to human γδ T cells (1996) (41)
Production of migration inhibitory factor and lympl toxin by non‐T cells (1975) (41)
Requirement for T cells in the production of migration inhibitory factor (1975) (40)
The cellular architecture of the antimicrobial response network in human leprosy granulomas (2020) (40)
PRODUCTS OF ACTIVATED LYMPHOCYTES (1973) (40)
Mycobacteriophage vector systems. (1989) (40)
Addressing Vaccine Hesitancy (2014) (40)
On the mechanism of human T cell suppression. (1989) (39)
Trypanosoma cruzi: infection of normal and activated mouse macrophages. (1977) (39)
Vaccine development. On relating immunology to the Third World: some studies on leprosy. (1989) (39)
RELATION OF THE MIGRATION INHIBITORY FACTOR (MIF) TO DELAYED‐TYPE HYPERSENSITIVITY REACTIONS (1970) (39)
Migration inhibitory factor and the cellular basis of delayed-type hypersensitivity reactions. (1970) (39)
Enumeration of activated thymus-derived lymphocytes by the virus plaque assay. (1973) (38)
The Transcriptional Regulator Rv0485 Modulates the Expression of a pe and ppe Gene Pair and Is Required for Mycobacterium tuberculosis Virulence (2009) (38)
Natural killers to rescue immune surveillance? (1982) (38)
Evolution, Safety, and Highly Pathogenic Influenza Viruses (2012) (37)
Inhibition of leukocyte migration by human breast‐cancer‐associated antigens (1976) (37)
DEMONSTRATION OF DELAYED HYPERSENSITIVITY TO SOLUBLE ANTIGENS OF CHEMICALLY INDUCED TUMORS BY INHIBITION OF MACROPHAGE MIGRATION (1969) (37)
Activation of murine macrophage cell lines. Possible involvement of protein kinases in stimulation of superoxide production. (1984) (37)
Interferons and natural killer cells. (1985) (37)
Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases (2017) (36)
1 – THE ASSAY OF INHIBITION OF MACROPHAGE MIGRATION AND THE PRODUCTION OF MIGRATION INHIBITORY FACTOR (MIF) AND SKIN REACTIVE FACTOR (SRF) IN THE GUINEA PIG* (1971) (35)
Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States (2017) (35)
Susceptibility of mice to acute and persistent measles infection (1978) (35)
Experimental allergic optic neuritis (EAON) in the rabbit: A new model to study primary demyelinating diseases (1975) (35)
Molecular regulation of human interleukin 2 and T-cell function by interleukin 4. (1993) (35)
Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads (1994) (34)
Major histocompatibility complex class I-restricted T cells are necessary for protection against M. tuberculosis in mice. (1993) (34)
Rethinking Biosafety in Research on Potential Pandemic Pathogens (2012) (33)
New approaches to vaccine development. (1989) (33)
Tuberculosis. Back to a frightening future. (1992) (32)
IgE-binding factors from mouse T lymphocytes. I. Formation of IgE-binding factors by stimulation with homologous IgE and interferon. (1983) (32)
THE PRODUCTION OF VESICULAR STOMATITIS VIRUS BY ANTIGEN- OR MITOGEN-STIMULATED LYMPHOCYTES AND CONTINUOUS LYMPHOBLASTOID LINES (1973) (32)
Growth of Trypanosoma cruzi in a cloned macrophage cell line and in a variant defective in oxygen metabolism (1983) (32)
Vitamin D3–Triggered Antimicrobial Response—Another Pleiotropic Effect beyond Mineral and Bone Metabolism Toll-Like Receptor Triggering of a Vitamin D–Mediated Human Antimicrobial Response. Science 311: 1770–1773, 2006 (2006) (32)
IL-26 contributes to host defense against intracellular bacteria. (2019) (31)
Vaccine visions and their global impact (1998) (31)
Molecular cloning of a gene selectively induced by gamma interferon from human macrophage cell line U937 (1989) (31)
Dual RNA-Seq of Human Leprosy Lesions Identifies Bacterial Determinants Linked to Host Immune Response. (2019) (31)
WHO needs change (2011) (30)
In vitro methods in cell-mediated immunity in man. (1971) (30)
Neutral proteinases secreted by macrophages degrade basic protein: a possible mechanism of inflammatory demyelination. (1978) (30)
A Perspective on AIDS Vaccines (1996) (30)
Isolation of a heterogeneous population of temperature-sensitive mutants of measles virus from persistently infected human lymphoblastoid cell lines (1978) (29)
Immunogenic potentials of copolymer I in normal human lymphocytes (1985) (29)
Transfer of delayed-type hypersensitivity. A critical review and experimental study in the guinea pig. (1967) (29)
Induction of cell-mediated immunity to Mycobacterium leprae in guinea pigs (1979) (29)
Studies on demyelination by activated lymphocytes in the rabbit eye. I. Effects of a mononuclear cell infiltrate induced by products of activated lymphocytes. (1977) (29)
Macrophages and delayed-type hypersensitivity. (1970) (29)
Monoclonal antibodies against mycobacterial antigens. (1985) (28)
Role of Tl and T2 Cytokines in the Response to Mycobacterium tuberculosis (1996) (28)
Trypanosoma cruzi: ability of T-cell-enriched and -depleted lymphocyte populations to passively protect mice. (1980) (28)
Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV‐seronegative volunteers (1995) (28)
Properties of protein kinase and adenylate cyclase‐deficient variants of a macrophage‐like cell line (1979) (28)
Immunological changes in multiple sclerosis (1980) (27)
Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus. (1983) (26)
Lessons from SARS (2003) (26)
Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. (2016) (26)
Mechanisms of Defense against Intracellular Pathogens Mediated by Human Macrophages. (2016) (25)
Occurrence of restricted suppressor T-cell activity in man (1977) (25)
Recognition of nonpeptide antigens by T cells (1996) (25)
Transfer of Delayed -Type Hypersensitivity (1967) (24)
Mycobacterium bovis DeltaleuD auxotroph-induced protective immunity against tissue colonization, burden and distribution in cattle intranasally challenged with Mycobacterium bovis Ravenel S. (2007) (24)
Mechanism of selective nonspecific cell-mediated cytotoxicity of virus-infected cells (1976) (24)
Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration. (1970) (24)
An immunological approach (1976) (23)
Asian flus in ethnographic and political context: A biosocial approach (2008) (23)
Genetic determination of the meso-diaminopimelate biosynthetic pathway of mycobacteria (1994) (23)
Priorities for Global Research and Development of Interventions (2006) (23)
Molecular Genetic Strategies for Identifying Virulence Determinants of Mycobacterium tuberculosis (1994) (23)
Primary in vitro sensitisation of human T cells (1977) (22)
Transfer of Delayed-Type Hypersensitivity (Part 1 of 3) (1967) (22)
Formation of IgE-binding factors by rat T lymphocytes. I. Induction of IgE-binding factors by poly I:C and interferon. (1981) (22)
Tuberculosis and leprosy. (1988) (21)
In vivo evidence for metabolic shifts in the differentiating slime mold. (1961) (21)
The Salzburg Statement on Vaccination Acceptance (2019) (21)
Bettering BCG: a tough task for a TB vaccine? (2013) (21)
Generation of a Live Attenuated Influenza Vaccine that Elicits Broad Protection in Mice and Ferrets. (2017) (20)
The interaction of Mycobacterium tuberculosis with macrophages: a study of phagolysosome fusion. (1993) (19)
Role of macrophage oxidative metabolism in resistance to vesicular stomatitis virus infection (1982) (19)
Generation and characterization of monoclonal antibodies to 28-, 35-, and 65-kilodalton proteins of Mycobacterium tuberculosis (1988) (19)
New Promise for Vaccines against Tuberculosis. (2018) (19)
INTERFERON AND NK CELLS IN RESISTANCE TO PERSISTENTLY VIRUS-INFECTED CELLS AND TUMORS (1980) (19)
Genetics and developing countries (2001) (18)
Immune regulation: learning from leprosy. (1993) (18)
Regulation of macrophage growth and antiviral activity by interferon- gamma (1989) (18)
Immunity to infection (1991) (18)
IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells (2019) (18)
Use of the macrophage migration inhibition test to monitor fractionation of soluble antigens of chemically induced sarcomas of inbred guinea pigs. (1972) (17)
Avian and pandemic influenza: a biosocial approach. Introduction. (2008) (17)
Complementation analysis of measles virus mutants isolated from persistently infected lymphoblastoid cell lines (1980) (17)
Development of genetic systems for the mycobacteria. (1989) (17)
Safe Vaccinations for a Healthy Nation: Increasing US Vaccine Coverage Through Law, Science, and Communication. (2019) (17)
The United States needs a national vaccine authority. (1994) (16)
Mycobacterium tuberculosis Transfer RNA Induces IL-12p70 via Synergistic Activation of Pattern Recognition Receptors within a Cell Network (2018) (16)
Sustainable health: A new dimension of sustainability science (2007) (16)
THE REDUCTIVE DISSOCIATION OF RABBIT IMMUNE GLOBULIN IN SODIUM DODECYLSULFATE. (1964) (15)
A Neglected Epidemic. (2018) (15)
Decreased expression of H-2 antigens following acute measles virus infection. (1981) (15)
Biochemical analysis of mutants of a macrophage cell line resistant to the growth-inhibitory activity of interferon (1984) (15)
Genetic approaches to the mechanism of macrophage functions. (1978) (15)
Autophagy links antimicrobial activity with antigen presentation in Langerhans cells. (2019) (14)
INTERFERON, NK CELLS AND PERSISTENT VIRUS INFECTION * (1980) (14)
Enlightened self-interest and the control of tuberculosis. (2005) (14)
A microbial minimalist (1995) (14)
Blocking of MLC stimulation by anti-Ia sera: studies with the virus plaque assay. (1976) (13)
New Strategies for Leprosy and Tuberculosis and for Development of Bacillus Calmette‐Guérin into a Multivaccine Vehicle (1989) (13)
Biomedical science and the Third World: under the volcano. (1989) (13)
Back to the future: Rethinking global control of tuberculosis (2016) (13)
Identification of a genomic fragment of Mycobacterium tuberculosis responsible for in vivo growth advantage. (1993) (13)
Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus. (1985) (12)
Universal health coverage and intersectoral action for health : key messages from Disease Control Priorities , 3 rd edition (2019) (12)
Mechanism of immunologic unresponsiveness: a new approach. (1966) (11)
Disease Control Priorities, Third Edition (Volume 6) (2017) (11)
Tolerance to a defined chemical hapten produced in adult guinea-pigs after thymectomy. (1966) (11)
Direct presentation of non-peptide prenyl pyrophosphate antigens to human gamma delta T cells. (1996) (11)
Tuberculosis in 2020 - New Approaches to a Continuing Global Health Crisis. (2020) (11)
TREM2 macrophages induced by human lipids drive inflammation in acne lesions (2022) (11)
Mechanisms in Macrophages Through a P 2 X Radical-Mediated Bacterial Killing Cutting Edge : Purinergic Signaling Regulates (1999) (11)
Infection of Mice with Aerosolized Mycobacterium tuberculosis: Use of a Nose-Only Apparatus for Delivery of Low Doses of Inocula and Design of an Ultrasafe Facility (2002) (11)
A T Helper Cell 2 ( Th 2 ) Immune Response against Non-self Antigens Modifies the Cytokine Profile of Autoimmune T Cells and Protects against Experimental Allergic Encephalomyelitis (1997) (10)
On the particularity of pathogens (2000) (10)
Inhibition of plasminogen activator secretion by cyclic AMP in a macrophage-like cell line. (1978) (10)
The future of public health (1999) (10)
Notes on the pathogenesis of multiple sclerosis (1978) (10)
Immunity to infection (1991) (9)
Modulation of Fc-receptor expression and Fc-mediated phagocytosis in variants of a macrophage-like cell line. (1981) (9)
Public-health priorities in the industrialised world (2000) (9)
From Financing to Fevers: Lessons of an Antimalarial Subsidy Program (2012) (9)
Regulatory variants for the expression of H-2 antigens. II. Level of discrimination of cell-mediated cytolysis. (1976) (9)
Selective viral immunosuppression of the graft-versus-host reaction (1977) (9)
INITIATION OF PRIMARY DEMYELINATION IN VIVO BY A PLASMINOGEN ACTIVATOR (UROKINASE) (1980) (9)
A Commercial Preparation of Catalase Inhibits Nitric Oxide Production by Activated Murine Macrophages: Role of Arginase (2000) (9)
Public health in transition. (2005) (9)
Persistent viral infection affects tumorigenicity of a neuroblastoma cell line. (1985) (9)
Studies of the mixed lymphocyte reaction by the virus plaque assay. (1975) (8)
A Perspective on Issues Relating to Future Vaccines (1995) (8)
Effects of Protein Calorie Malnutrition on Mice Infected with BCG (1997) (8)
Universal Health Coverage and Intersectoral Action for Health (2017) (8)
Dual RNAseq of human leprosy lesions identifies bacterial determinants linked to host immune response (2018) (8)
Chip Shots--Will Functional Genomics Get Functional? (2001) (8)
Natural killer cells in resistance to virus-infected cells (1982) (7)
VIRAL MUTATION IN PERSISTENT INFECTION (1980) (7)
T-lymphocyte clones from leprosy skin lesions. (1986) (7)
The unspecificity of cellular reactions. (1980) (7)
Response of a continuous macrophage-like cell line to MIF. (1979) (7)
SESSION I – METHODS FOR STUDY OF MEDIATORS (1971) (7)
IL-4-Deficient C 57 BL / 6 Mice and BALB / c Mice Encephalomyelitis as Demonstrated in Severity in Experimental Allergic A Critical Role for IL-4 in Regulating Disease (1998) (6)
Genome sequences. A microbial minimalist. (1995) (5)
Immunology of bacteria and parasites. (1989) (5)
Mechanisms of immunological unresponsiveness in the spectra of leprosy and leishmaniasis. (1988) (5)
The Global Health System: Institutions in a Time of Transition (2010) (5)
Immunology of an infectious diseas: Pathogenesis and protection in tuberculosis (1999) (5)
Transformation of BCG with plasmid DNA. (1989) (5)
A vital opportunity for global health Supporting the World Health Organization at a critical juncture (1997) (5)
Leprosy: Awakening the unresponsive lymphocyte (1983) (5)
WHO's Next - The United States and the World Health Organization. (2020) (5)
Genes for the protein antigens of the tuberculosis and leprosy bacilli (1985) (5)
AIDS vaccine strategies (1987) (5)
Induction of direct antimicrobial activity through mammalian toll-like receptors. (2001) (5)
Macrophage proteases and rheumatic diseases: Regulation of plasminogen activator by thymus-derived lymphocytes (2005) (5)
Ethical issues in AIDS vaccine development. (1999) (4)
Health research and developing nations. (1976) (4)
Diminution by vesicular stomatitis virus of acute graft vs host mortality in mice. (1979) (4)
WHO Expert Committee on Leprosy. (2012) (4)
Rationales for vaccines against leprosy. (1983) (4)
On the enzymic conversion of Δ4-3-hydroxy steroids to Δ4-3-ketones (1957) (4)
Effects of fucose-binding lectins and Tuftsin on the migration of guinea pig peritoneal exudate cells☆☆☆ (1976) (4)
News about carcinogens: what's fit to print. (1979) (3)
Genetic and Functional Studies of Continuous Macrophage-Like Cell Lines (1980) (3)
The virus plaque assay and the effector cell in cell-mediated immune reactions. (1972) (3)
Summary of round table discussion on methods concerned with leukocyte migration. (1972) (3)
Immunology. Chip shots--will functional genomics get functional? (2001) (3)
Prazosin , an a 1-adrenergic receptor antagonist , suppresses experimental autoimmune encephalomyelitis in the Lewis rat ( delayed-type hypersensitivity / edema / blood-brain barrier / autoimmunity ) (3)
THE EFFECT OF MACROPHAGE DEPLETION ON THE EXPRESSION OF EAE IN THE LEWIS RAT: 14 (1979) (3)
THE ROLE OF H-2 IN RESISTANCE AND SUSCEPTIBILITY TO MEASLES VIRUS INFECTION (1980) (3)
Rethinking how to address the world’s largest infectious killer in the world’s largest country (2016) (3)
A new threat to world health. (1988) (3)
Analysis of vaccines prepared from armadillo-derived M. leprae; results of an inter-laboratory study coordinated by the World Health Organization. Immunology of Mycobacterial Diseases (IMMYC) Steering Committee, World Health Organization. (1995) (3)
Deficient mitogen-induced virus plaque-forming cells in patients with localized cancer. (1977) (3)
Genetic determination of the meso-diaminopimelate biosynthetic pathway of mycobacteria (1997) (3)
A kinetic approach to cellular interaction in delayed-type hypersensitivity. (1972) (3)
Letter to the Editor: THE METABOLISM OF 3α,17α-DIHYDROXYPREG-NANE-11,20-DIONE-4-C14IN VIVO (1960) (2)
Proceedings: The number and nature of tuberculin hypersensitive lymphocytes. (1971) (2)
Tuberculosis: old lessons unlearnt? (1997) (2)
CD1c-reactive, Th2 cytokine producing T-cells in human autoimmune disease (1998) (2)
Immunological studies on human placental trophoblast components of potential utility for fertility regulation. (1976) (2)
Expression of Prostate Specific Molecules in Bacille Calmette‐Guerin: An Immunotherapeutic Approach to Prostate Cancer (2001) (2)
MECHANISM OF NK CELL LYSIS (1982) (2)
VIRUS PLAQUE ASSAY FOR ANTIGEN-SENSITIVE CELLS IN DELAYED HYPERSENSITIVITY (1971) (2)
Support for Global Health (2010) (2)
OBSERVATIONS ON SUPPRESSOR T CELLS AND LEPROSY (1992) (2)
INTERACTIONS BETWEEN INTERFERON AND CELLS OF THE IMMUNE SYSTEM (1982) (2)
The 13th Kellersberger memorial lecture, 1987. A view of vaccines against leprosy and a reflection on "appropriate science" and the Third World. (1988) (2)
The search for better vaccines against TB (2020) (2)
Studies on Delayed-Type Hypersensitivity Including Attempts to Effect Transfer in Guinea Pigs with Subcellular Materials (1963) (2)
STUDIES OF HUMAN NK CELL FUNCTION IN CHRONIC DISEASES (1982) (2)
Strengthening biomedical science and institutions (1987) (2)
Immunogenic RNA in cell-mediated immunity. Introduction: transfer factor (s) and delayed-type hypersensitivity. (1973) (1)
Macrophage oxidative metabolism: a defense mechanism against virus infection? (1983) (1)
Macrophage variants in oxygen metabolism: a model for chronic granulomatous disease (1981) (1)
Teles Anti-Mycobacterial Responses Triggered Human − Type I Interferon Suppresses Type II Interferon (2013) (1)
An ordinary mortal's guide to the molecular biology of mycobacteria. (1989) (1)
Virus plaque assay and enumeration of effector cells in mixed lymphocyte cultures. (1973) (1)
DEMYELINATING ACTIVITY IN THE RABBIT EYE MODEL OF PERIPHERAL BLOOD CELLS AND SERUM FROM PATIENTS WITH MULTIPLE SCLEROSIS (1978) (1)
Immunity to infection. (1991) (1)
The Interferon—Natural Killer Cell System in Multiple Sclerosis (1982) (1)
Insights into Immunoregulation and Pathogenesis from a Third World Disease (1989) (1)
Induction ofCell-Mediated Immunity toMycobacterium leprae inGuinea Pigs (1979) (1)
Enumeration of activated and cytotoxic t-lymphocytes by the virus plaque assay. Abstr. (1973) (1)
INTRODUCTION: TRANSFER FACTOR(S) AND DELAYED‐TYPE HYPERSENSITIVITY (1973) (1)
An ordinary mortal's guide to the molecular biology of mycobacteria. (1989) (1)
Perspective on molecular immunology and modulation of immune responses. (1986) (1)
Microbial infection & immune defence (2000) (1)
Detection of activated, non-dividing T-cells by the virus plaque assay. (1973) (1)
Children's vaccine initiative ad hoc committee on an investment strategy for measles control (1994) (1)
Molecular Approaches to Developing a Vaccine for Leprosy (1989) (1)
The Cellular Basis of the Immune Response (1974) (1)
Dr. Jacinto Convit (1913–2014) (2014) (1)
16 – A SIMPLIFIED ASSAY FOR THE CYTOTOXIC ACTIVITY (LYMPHOTOXIN) OF LYMPHOCYTE CULTURE SUPERNATANTS (1971) (1)
BCG: Its Impact on Tuberculosis and Relevance to Autoimmune Disease (2018) (1)
[Towards a vaccine against leprosy]. (1985) (1)
WHO Expert Committee on Leprosy. (1988) (0)
The Future of Lymphokines (1981) (0)
ANALYSIS OF THE MECHANISM OF IMMUNE- MEDIATED DEMYELINATION IN THE RABBIT EVE: 53 (1976) (0)
ANTI-TB MONOCLONAL ANTIBODIES FOR THE DETECTION OF M. TUBERCULOSIS. 1019 (1996) (0)
Experimental Medicine Edited by R Recognition of Viral Glycoproteins by Influenza Α-specific Cross-reactive Cytolytic Τ Lymphocytes* Materials and Methods (0)
Box 11.3, New Strategies for TB Diagnosis (2017) (0)
Single-cell RNA-sequencing of leprosy skin lesions reveals a titin (TTN) expressing T cell subset associated with the progressive disease (2020) (0)
Leprosy vaccine [3] (1994) (0)
Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus (viral immunity/immune surveillance/gene transfer/ts mutants and cell surface antigens) (2016) (0)
HETEROGENEITY AND REGULATION OF THE NATURAL KILLER CELL SYSTEM (1982) (0)
The Tobacco Wars' Lessons for the Vaccination Wars. (2022) (0)
MECHANISMS OF CELL-MEDIATED IMMUNITY (1976) (0)
Immunoregulation and Cytokine Patterns in Leprosy (1996) (0)
Global Public Health Issues (2005) (0)
Transfer of Delayed-Type Hypersensitivity (Part 2 of 3) (1967) (0)
Round Table Conference on Allergen Standardization (1971) (0)
Rethinking how to address the world’s largest infectious killer in the world’s largest country (2016) (0)
AN APPROACH TO THE STUDY OF PHOSPHOPROTEIN AND CYCLIC NUCLEOTIDE METABOLISM IN CULTURED CELL LINES WITH DIFFERENTIATED PROPERTIES1 (1979) (0)
Adjuvants and in vitro antibody production. (1973) (0)
Transfer of Delayed-Type Hypersensitivity (Part 3 of 3) (1967) (0)
Response from Flynn and Bloom (1993) (0)
Crystal structure of the immunodominant chaperonin-10 of Mycobacterium leprae (1996) (0)
Fundamentals of Public Health - A New Perspective Series. (2021) (0)
Musings on microbial genomes (1999) (0)
by Altering Membrane Permeability Granulysin, a T Cell Product, Kills Bacteria (2000) (0)
Dissection of Mycobacterium tuberc recombinant DNA (Xgtll expression vector/monoclonal antibodies/human pathogens) (2016) (0)
Methods of leprosy prevention (1990) (0)
Leprosy vaccine (1994) (0)
A potential method for enumerating antigen-sensitive cells in delayed hypersensitivity. (1971) (0)
Immunological unresponsiveness in leprosy and its relevance to immunoregulation in man (1984) (0)
Transiently Diminished Levels of IFN-Mice Deficient in CD 4 T Cells Have (1999) (0)
COLD-SENSITIVE MUTANTS OF MEASLES VIRUS 847 blastoma C 1300 was infected with wild-type Edmonston measles (0)
Construction and analysis of mycobacteriophage expression libraries (1991) (0)
THE ASSAY OF INHIBITION OF MACROPHAGE MIGRATION AND THE PRODUCTION OF MIGRATION INHIBITORY FACTOR (MIF) AND SKIN REACTIVE FACTOR (SRF) IN THE GUINEA PIG**Portions of this method have been published in the Europ. J. Clin. Biol. Res. 15: 460 (1970). (1971) (0)
Reviewer list for 2003 (2003) (0)
10 – FUTURE CHALLENGES FOR VACCINES AND IMMUNIZATION (2003) (0)
blood donors Blood donor Diagnosis Extent of disease Age Sex History of transfusion Carcinoma of bladder Carcinoma of bladder and 6 other primary tumors over past 50 yr Melanoma Carcinoma of bladder Carcinoma of bladder Melanoma (2007) (0)
Pre-immunization with highly immunogenic proteins protects against EAE by shifting the th1/th2 profile of the encephalitogenic T cells (1995) (0)
Transformation of BCG with plasmid DNA'. 'The first human vaccination with this attenuated strain, named Bacille-Calmette-Guerin (BCG), was applied in 1921 in Paris' (Acta Leprologica) (1989) Page 256)) (1989) (0)
GENERAL DISCUSSION (1973) (0)
Preface (1989) (0)
On the enzymic conversion of delta 4-3-hydroxy steroids to delta 4-3-ketones. (1957) (0)
The metabolism of 3 alpha, 17 alpha-dihydroxypregnane-11, 20-dione-4-C14 in vivo. (1960) (0)
Assay of Double-stranded RNA-dependent PllelF-2 a Protein Kinase Activity (2003) (0)
Immunology and Reciprocity (1993) (0)
Intracellular Pathogens for Antimicrobial Activity against Macrophages Acquire Neutrophil Granules (2006) (0)
EXPRESSION OF PROSTATE SPECIFIC MOLECULES IN BCG-POTENTIAL FOR IMMUNOTHERAPY (1999) (0)
"Mechanisms of cell-mediated immunity" (第25回日本アレルギ-学会総会記録) (1976) (0)
WHO expert committee on leprosy. (1977) (0)
Antigenic Variation in Viruses (2016) (0)
Reconstitution of a variant macrophage cell line defective in oxygen metabolism with a H 202-generating system ( oxidative cytocidal mechanisms / Trypanosoma cruzi / glucose oxidase ) (2003) (0)
Functional y6 T-lymphocyte Defect Associated with Human Immunodeficiency Virus Infections (2007) (0)
Erratum: Genetic determination of the meso-diaminopimelate biosynthetic pathway of mycobacteria (Journal of Bacteriology 176:14 (4424-4429)) (1997) (0)
Selective viral immunosuppresion of the graft-versus-host reaction. (1977) (0)
Audio Interview: Do the Tobacco Wars Offer Any Lessons for the Vaccine Wars? (2022) (0)
A recombinant circumsporozoite protein vaccine against malaria. (1997) (0)
Medical morals: an exchange. (2001) (0)
A doctor's odyssey (2021) (0)
A TB scientist reflects on the continuing struggle against a global threat. Interview by Mike Mitka. (2005) (0)
Muddying the water: a chairman's prerogative. (1972) (0)
Pathogenesis of a Third World disease: lessons from leprosy. (1988) (0)
Lysogeny andtransformation inmycobacteria: Stable expression of foreign genes (Mycobacterium tuberculosis typus bovinus var.Bacille-Calmette-Gudrin/shuttle phasmid/electroporation/shuttle plasmid/vaccines) (1988) (0)
Investing in the World Health Organization [editorial] (1999) (0)
Functional y 6 T-lymphocyte Defect Associated with Human Immunodeficiency Virus Infections (2007) (0)
Letter from Barry R. Bloom to Joshua Lederberg (1996) (0)
Lupus Erythematosus Provide Help for IgG Human Double-Negative T Cells in Systemic (2000) (0)
Selected Reference(s) (0)
Seventh International Conference on Lymphocyte Activation and Immune Regulation: Molecular Determinants of Microbial Immunity Newport Beach, California, USA, February 6–8, 1998 (2004) (0)
ANTIBODY-DEPENDENT CELL-MEDIATED DEMYELINATION IN THE RABBIT EYE: 16 (1977) (0)
Delayed Hypersensitivity and Tumor Specific Immunity (1969) (0)
[Learning from leprosy: a look at immunology and the Third World]. (1986) (0)
Nature of syngeneic proliferating cells in spleens of mice undergoing graft versus host (gvh) reactions. Abstr. (1975) (0)
Cell Network of Pattern Recognition Receptors within a Induces IL-12 p 70 via Synergistic Activation Transfer RNA Mycobacterium tuberculosis (2018) (0)
Still Learning from Leprosy (1993) (0)
Introductory Remarks on Immunology and Oncology (1972) (0)
Nk activity in murine chagas' disease. Abstr. (1982) (0)
Awakening the unresponsive lymphocyte. (1983) (0)
Interferon, nk cells and tumorigenicity of a human hepatoma cell line secreting hepatitis b surface antigen in immuno- suppressed nude mice. Abstr. (1981) (0)
New approaches to macrophage function. (1980) (0)
Tuberculosis: old lessons unlearnt? [letter] (1997) (0)
"In vitro" tests for cell-mediated immunity. (1970) (0)
Immunological significance of Mycobacterium leprae cell walls (cell-mediated immunity/delayed-type hypersensitivity/peptidoglycan-protein complex/leprosy/precursor frequency analysis) (2016) (0)

This paper list is powered by the following services:

Other Resources About Barry Bloom

en.wikipedia.org

What Schools Are Affiliated With Barry Bloom?

Barry Bloom is affiliated with the following schools: